Northern Arc Capital, a leading Indian private equity firm, saw a remarkable increase in its share price recently. The company's shares listed at ₹351 apiece on the Bombay Stock Exchange (BSE), a premium of 33.46% over the IPO price of ₹263 per share. On the National Stock Exchange (NSE), the shares opened at ₹350, marking a similar premium.
Analysts attribute the strong performance to several factors. Firstly, Northern Arc Capital has a track record of successful investments in the Indian growth market. The company has invested in over 30 companies, including Paras Pharmaceuticals, Eureka Forbes, and Subex. Many of these investments have yielded significant returns for the company and its investors.
Secondly, Northern Arc Capital's IPO was well-received by institutional investors. The company's offer was oversubscribed by 111 times, highlighting the strong demand for its shares. This strong demand has continued in the aftermarket, with the share price rising steadily since listing.
Thirdly, the Indian stock market has been performing well in recent months. The BSE Sensex index has reached record highs, and investors are optimistic about the future prospects of the Indian economy. This positive sentiment has also contributed to the rise in Northern Arc Capital's share price.
Overall, the strong performance of Northern Arc Capital's share price is a reflection of the company's strong fundamentals, the positive sentiment in the Indian stock market, and the high demand for its shares.
It is important to note that the share price of any company can fluctuate, and there is no guarantee of future returns. However, Northern Arc Capital's strong track record and the positive outlook for the Indian economy suggest that the company's shares may continue to perform well in the future.
If you are considering investing in Northern Arc Capital, it is important to do your own research and consult with a financial advisor to determine if the investment is right for you.